SUSAN SMITH: Open Payments
NPI 1720006349 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$852 in 23 payments from 10 companies in 2025. Trend: 2023 $2,654 · 2024 $2,162 · 2025 $852
Food & beverage: $647Education: $205
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $241 |
| ABBVIE INC. | 6 | $215 |
| GENZYME CORPORATION | 2 | $116 |
| LEO Pharma Inc. | 3 | $59 |
| Novartis Pharmaceuticals Corporation | 1 | $53 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $50 |
| UCB, Inc. | 1 | $37 |
| Amgen Inc. | 2 | $30 |
| Lilly USA, LLC | 1 | $25 |
| Botanix SB Inc | 1 | $25 |
Products named: TREMFYA, SKYRIZI, COSENTYX, ILUMYA, ANZUPGO, Bimzelx, Otezla, TALTZ.
Industry payments across NV — which companies pay providers there.
